What is Biogen's lease impairment?

Biogen (BIIB) reported lease impairment of $13.23M in Q4 2025.

What does lease impairment mean?

Charges recognized when the carrying amount of a right-of-use asset related to a lease exceeds its recoverable amount. This reflects a decline in the utility or value of leased office or facility space.

Biogen BIIB Lease impairment

Lease impairment at other companies

Monro, Inc.MNRO

$2.2M0.0%

Boston BeerSAM

$150K—

IdentiveINVE

$131K—

BankUnitedBKU

$51.75K+283%

Tetra TechTTEK

$0—

ZymeworksZYME

$79K—

Other financials

Income statement

See full

Revenue$2.5B+1.9%

Gross profit$1.8B+0.8%

Operating income$610.7M—

Net income$319.5M+32.8%

EPS (diluted)$2.15+31.1%

Balance sheet

See full

Cash & equivalents$3.4B+30.2%

Total debt$6.6B+34.7%

Total equity$18.7B+9.9%

Total assets$29.5B+5.2%

Cash flow

See full

Operating cash flow$645.5M+149%

CapEx$51.2M+38.0%

Free cash flow$594.3M+167%

Valuation

See full

Market cap$31.9B+71.5%

Enterprise value$35.08B+56.4%

P/E22.5×+10.3×

P/S3.2×+1.3×

Profitability

See full

Gross margin75.5%-0.1pp

Operating margin22.9%—

Net margin14.3%-0.8pp

FCF margin24.4%-0.4pp

Returns & leverage

See full

Return on equity8%-1.2pp

Debt / equity0.4×+0.1×

Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseImpairmentLoss.

The official record: Biogen’s 10-K, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's lease impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's lease impairment?: Biogen (BIIB) reported lease impairment of $13.23M in Q4 2025.
What does lease impairment mean?: Charges recognized when the carrying amount of a right-of-use asset related to a lease exceeds its recoverable amount. This reflects a decline in the utility or value of leased office or facility space.